Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)-KCSG GY10-10
Sook Hee Hong, Soohyeon Lee, Hoon Gu Kim, Hyo Jin Lee, Kyung Hae Jung, Sang Cheol Lee, Na Ri Lee, Jina Yun, In Sook Woo, Kyong Hwa Park, Kyoung Ha Kim, Ho Young Kim, Sun Young Rha, Jae Ho Byun
Dive into the research topics of 'Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)-KCSG GY10-10'. Together they form a unique fingerprint.